Risk factors for encephalitis and death from West Nile virus infection - PubMed (original) (raw)
Boubour A, Kim CY, Torres S, Jia DT, Hess E, Liu S, Sun Y, Fong K, Epstein S, Yan H, Luche N, Gao K, Glassberg B, Harmon M, Hoang H, Navis A, Schorr E, Gofshteyn JS, Yeshokumar AK, Thakur KT. Boubour A, et al. Neurohospitalist. 2024 Oct;14(4):396-405. doi: 10.1177/19418744241263138. Epub 2024 Jun 17. Neurohospitalist. 2024. PMID: 39308466
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients.
Gervais A, Rovida F, Avanzini MA, Croce S, Marchal A, Lin SC, Ferrari A, Thorball CW, Constant O, Le Voyer T, Philippot Q, Rosain J, Angelini M, Pérez Lorenzo M, Bizien L, Achille C, Trespidi F, Burdino E, Cassaniti I, Lilleri D, Fornara C, Sammartino JC, Cereda D, Marrocu C, Piralla A, Valsecchi C, Ricagno S, Cogo P, Neth O, Marín-Cruz I, Pacenti M, Sinigaglia A, Trevisan M, Volpe A, Marzollo A, Conti F, Lazzarotto T, Pession A, Viale P, Fellay J, Ghirardello S, Aubart M, Ghisetti V, Aiuti A, Jouanguy E, Bastard P, Percivalle E, Baldanti F, Puel A, MacDonald MR, Rice CM, Rossini G, Murray KO, Simonin Y, Nagy A, Barzon L, Abel L, Diamond MS, Cobat A, Zhang SY, Casanova JL, Borghesi A. Gervais A, et al. J Exp Med. 2023 Sep 4;220(9):e20230661. doi: 10.1084/jem.20230661. Epub 2023 Jun 22. J Exp Med. 2023. PMID: 37347462 Free PMC article.